All the participants of the ACCORD 2024 Conference are offered an opportunity to publish a conference paper in three ways:
1. Special Issue “Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers 3.0”
IJMS is an
international peer-reviewed open-access journal providing an advanced forum for
biochemistry, molecular and cell biology, molecular biophysics, molecular
medicine, and all aspects of molecular research. It is published semi-monthly
online by the Multidisciplinary Digital Publishing Institute (MDPI), Basel,
Switzerland. The conference paper will publicize the research presented and
discussed at our Conference as an invited lecture, short oral presentation, or
poster (printed poster or spotlight poster presentation). The current journal
rank is JCR – Q1 (Biochemistry & Molecular Biology) and it scored 140 points of
the Polish Ministry of Education and Science. The deadline for the submission
of the manuscript is June 30, 2024.
Manuscripts
from the ACCORD 2024 Conference are welcome from all the disciplines of drug
sciences, starting from drug design and molecular modeling, molecular target
identification, leads generation and optimization, through medicinal and
pharmaceutical chemistry, drug carriers and dosage forms development, in silico, in vitro, ex vivo, and in vivo evaluations, to preclinical
trials. Manuscripts from other fields related to the drug development process
are also invited. The manuscripts will undergo regular peer review before being
published online. Information for authors, containing links to useful resources
and instructions is available on the journal website https://www.mdpi.com/authors.
2. Acta Poloniae Pharmaceutica
Regular or special issue, depending on the number of manuscripts, of Acta Poloniae Pharmaceutica – Drug Research of the Polish Pharmaceutical Society (https://www.ptfarm.pl/acta–poloniaepharmaceutica). The journal currently has 100 points of the Polish Ministry of Education and Science. It is recommended to include in the manuscript the footnote on the front page “Presented in part at the ACCORD 2024 Conference, Warsaw, Poland, May 23-25, 2024”. The deadline for submission of the manuscripts is June 30, 2024.
3. Prospects in Pharmaceutical Science
Regular/special issue, depending on the number of manuscripts, of the Prospects in Pharmaceutical Science (https://prospects.wum.edu.pl/index.php/pps/about) of the Medical University of Warsaw. The new journal currently has 40 points of the Polish Ministry of Education and Science. The journal offers Open Access publishing of original articles and reviews in Polish (with English abstract) or English in the field of pharmaceutical sciences: analysis, biochemistry, biopharmacy, biotechnology, clinical pharmacy, phytochemistry, herbal medicine, pharmaceutical care, drug synthesis, pharmaceutical technology, food, and nutrition and related sciences, such as pharmacoeconomic, history of pharmacy or didactics in medical professions. Prospects in Pharmaceutical Sciences offers immediate Open Access to its publications, permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, free of any charge. Full-text access to the published content of the journal is presented on the official website in the Archives section. The journal does not charge the authors Article Processing Charge, or any other fees. Prospects in Pharmaceutical Sciences is free for both authors and readers. The journal receives institutional and organizational support from the Medical University of Warsaw, Poland.